Here's why Global Health Limited has rocketed higher today

Global Health Limited (ASX:GLH) investors have lost over 50% in the last year, but a new contract win could change everything.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Global Health Limited (ASX: GLH) made the first step towards reversing a horror 12 months by announcing a new customer that pushed the share price up a massive 19% on Thursday morning. The company announced the implementation of its MasterCare ePAS patient administration system, LifeCard Patient Portal and HotHealth Managed Website at the new Hospitals for Specialist Surgery in Baulkham Hills, NSW.

So What: Bringing on a new practice is welcome news for patient shareholders that have suffered through inconsistent messages from management and the loss of a major contract to SA Health over the last 12 months. The loss of the contract, which actually was a failure of SA Health to upgrade from the legacy 1980s CHIRON system, proved earnings were not as resilient as shareholders believed.

Global Health announced that the lost contract would cost approximately 1.5 cents per share of earnings this year, or 34% of FY2014 earnings, despite stating previously that the business model had been de-risked due to 80% of revenues being recurring. This loss of confidence has been the catalyst for a number of analysts recommending selling the company.

What Now: The new contract is good news but is only for a single, 78 bed hospital, compared to the 64 hospital contract with SA Health. Earnings upside will be minimal, one would imagine, seeing as the announcement wasn't considered market sensitive. Many long-term shareholders, like yours truly, are sticking with Global Health because so many hospital and health organisations are calling for software just like Global Health's.

Analysts are predicting earnings per share of just 3.2 cents in the 2015 financial year, representing a price to earnings ratio of just 8.8 based on the last sale price of 28 cents. With a market capitalisation of just $8 million and no dividend on offer, Global Health is still a risky proposition and investors like me are far from certain about the integrity of management.

Motley Fool contributor Andrew Mudie owns shares in Global Health. You can find Andrew on Twitter @andrewmudie

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »